NFA
SGYP

Nationwide Fund Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Nationwide Fund Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-329,353
Closed -$955K – 2849
2017
Q3 		$955K Buy
329,353
+16,542
+5% +$56.4K ﹤0.01% 1817
2017
Q2 		$1.39M Buy
312,811
+10,982
+4% +$45.3K 0.01% 1596
2017
Q1 		$1.41M Buy
301,829
+25,113
+9% +$146K 0.01% 1568
2016
Q4 		$1.69M Sell
276,716
-2,733
-1% -$14.3K 0.01% 1489
2016
Q3 		$1.54M Buy
279,449
+160,990
+136% +$754K 0.01% 1526
2016
Q2 		$450K Buy
118,459
+54,960
+87% +$186K ﹤0.01% 2208
2016
Q1 		$175K Sell
63,499
-2,825
-4% -$10.2K ﹤0.01% 2597
2015
Q4 		$376K Buy
66,324
+1,519
+2% +$9.26K ﹤0.01% 2256
2015
Q3 		$343K Hold
64,805
– – ﹤0.01% 2311
2015
Q2 		$538K Sell
64,805
-2,403
-4% -$11.6K ﹤0.01% 2208
2015
Q1 		$311K Sell
67,208
-4,175
-6% -$13.6K ﹤0.01% 2479
2014
Q4 		$218K Sell
71,383
-879
-1% -$2.6K ﹤0.01% 2588
2014
Q3 		$201K Buy
72,262
+695
+1% +$2.52K ﹤0.01% 2683
2014
Q2 		$291K Buy
71,567
+9,722
+16% +$41.3K ﹤0.01% 2546
2014
Q1 		$328K Sell
61,845
-2,085
-3% -$11.7K ﹤0.01% 2262
2013
Q4 		$355K Sell
63,930
-821
-1% -$3.54K ﹤0.01% 2394
2013
Q3 		$292K Buy
64,751
+16,218
+33% +$72.7K ﹤0.01% 2482
2013
Q2 		$207K Buy
+48,533
New +$244K ﹤0.01% 2473

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nationwide Fund Advisors's SGYP Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 329,353 shares — an estimated $955K sold.

Nationwide Fund Advisors first reported a position in SGYP in Q2 2013 and held it in 18 quarters. The position peaked at $1.69M in Q4 2016. 150 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 329,353 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $955K.
  • Nationwide Fund Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.69M in Q4 2016.
  • 150 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.